US BANCORP \DE\ - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 46 filers reported holding REDHILL BIOPHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q3 2022$0
-100.0%
7020.0%0.00%
Q2 2022$1,000
-50.0%
7020.0%0.00%
Q1 2022$2,0000.0%7020.0%0.00%
Q4 2021$2,000
-33.3%
7020.0%0.00%
Q3 2021$3,000
+200.0%
702
+312.9%
0.00%
Q4 2020$1,0000.0%170
+56.0%
0.00%
Q3 2020$1,0001090.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2022
NameSharesValueWeighting ↓
BANK HAPOALIM BM 136,012$1,470,0000.33%
Family Management Corp 37,750$408,0000.28%
MENORA MIVTACHIM HOLDINGS LTD. 421,000$4,551,0000.18%
Migdal Insurance & Financial Holdings Ltd. 397,410$4,296,0000.10%
Orbimed Advisors 564,900$6,107,0000.06%
INGALLS & SNYDER LLC 41,250$446,0000.02%
MONETARY MANAGEMENT GROUP INC 3,000$32,0000.01%
Candriam S.C.A. 71,267$770,0000.01%
ETF MANAGERS GROUP, LLC 10,870$118,0000.01%
D.A. DAVIDSON & CO. 44,000$475,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders